Contact this trialFirst, we need to learn more about you.
Bruton's Tyrosine Kinase (BTK) Inhibitor
Ibrutinib for High-risk CLL/SLL
Recruiting1 awardPhase 2
Columbus, Ohio
This trial is testing ibrutinib with different vaccine therapies to see if it is a better treatment for patients with high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma who do not have any symptoms.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service